TABLE 4.
Formulation code | Particle size (nm) | Polydispersity index–PI | Zeta potential (mV) | Drug loading (%) | Encapsulation efficiency (%) |
C1 | 1073 | 0.200.03 | −10.40.9 | 1.20.1*** | 9.00.6*** |
C2 | 1126 | 0.200.02 | −11.40.9 | 2.30.3 | 18.22.1 |
C3 | 1394*** | 0.100.05* | −8.10.8* | 1.10.2*** | 8.41.4*** |
C4 | 1436*** | 0.120.04 | −10.30.1 | 1.50.1** | 11.60.9** |
Results are expressed as mean ± SD (n = 3). *signifies p < 0.05, **signifies p < 0.01, ***signifies p < 0.001 significant differences with respect to C2 formulation. C1, 6.7–31.3 kDa; C2, 31.3–57.6 kDa; C3, 57.6–91.6 kDa; C4, 91.6–111.5 kDa.